FY2028 Earnings Forecast for ARDT Issued By Leerink Partnrs

Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Leerink Partnrs issued their FY2028 earnings per share estimates for Ardent Health Partners in a note issued to investors on Thursday, April 24th. Leerink Partnrs analyst W. Mayo anticipates that the company will post earnings per share of $2.61 for the year. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share.

Ardent Health Partners (NYSE:ARDT - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion.

Several other equities research analysts also recently commented on ARDT. Truist Financial cut their price objective on Ardent Health Partners from $22.00 to $21.00 and set a "buy" rating for the company in a report on Monday, January 6th. Royal Bank of Canada cut their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating for the company in a research note on Tuesday, March 4th. Mizuho cut their target price on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. Morgan Stanley cut their target price on shares of Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a research note on Tuesday, January 21st. Finally, Guggenheim started coverage on shares of Ardent Health Partners in a report on Wednesday, April 9th. They issued a "buy" rating and a $16.00 target price on the stock. Two research analysts have rated the stock with a hold rating, nine have issued a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus target price of $20.58.

Ardent Health Partners Stock Performance

NYSE ARDT traded down $0.20 during trading on Monday, hitting $12.53. The stock had a trading volume of 60,136 shares, compared to its average volume of 397,742. The company's 50-day moving average price is $13.24 and its two-hundred day moving average price is $15.25. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners has a 12 month low of $11.31 and a 12 month high of $20.72.

Hedge Funds Weigh In On Ardent Health Partners

Several large investors have recently added to or reduced their stakes in the business. Ventas Inc. bought a new stake in Ardent Health Partners during the fourth quarter valued at $159,570,000. Franklin Resources Inc. purchased a new position in Ardent Health Partners in the 3rd quarter worth approximately $15,839,000. Segall Bryant & Hamill LLC purchased a new position in Ardent Health Partners in the 4th quarter worth approximately $4,478,000. Pier Capital LLC grew its position in shares of Ardent Health Partners by 70.1% in the 4th quarter. Pier Capital LLC now owns 373,904 shares of the company's stock worth $6,386,000 after buying an additional 154,077 shares during the last quarter. Finally, Geode Capital Management LLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth approximately $2,581,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.